GERI-TUSSIN- guaifenesin liquid 
Geri-Care Pharmaceuticals, Corp

----------

GeriCare- Tussin 693

In each 5 mL teaspoonful

Guaifenesin - 100 mg

Purpose

Expectorant

Uses

Warnings

Do not use

Ask a doctor before use if you have

Stop use and ask a doctor if cough lasts more than 7 days, comes back or is accompanied by fever, rash, or persistent headache. These could be signs of a serious condition.

If pregnant or breast-feeding,ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away

Directions

 adults and children 12 years and over 2 to 4 teaspoonfuls every 4 hours
 children under 12 years ask a doctor

Inactive ingredients: artificial and natural cherry flavor, citric acid, FD&C red #40, menthol, methylparaben, propylene glycol, propylparaben, purified water, sodium citrate, sucralose

Questions or comments? 1-800-540-3765

geri4

geri16

Tussin8oz

GERI-TUSSIN 
guaifenesin liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:57896-693
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN100 mg  in 5 mL
Inactive Ingredients
Ingredient NameStrength
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
FD&C RED NO. 40 (UNII: WZB9127XOA)  
MENTHOL (UNII: L7T10EIP3A)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
WATER (UNII: 059QF0KO0R)  
SODIUM CITRATE (UNII: 1Q73Q2JULR)  
SUCRALOSE (UNII: 96K6UQ3ZD4)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:57896-693-16473 mL in 1 BOTTLE; Type 0: Not a Combination Product05/01/2019
2NDC:57896-693-04118 mL in 1 BOTTLE; Type 0: Not a Combination Product06/05/2025
3NDC:57896-693-08237 mL in 1 BOTTLE; Type 0: Not a Combination Product12/01/2025
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01205/01/2019
Labeler - Geri-Care Pharmaceuticals, Corp (611196254)

Revised: 12/2025
Document Id: 4744e526-723f-2ff0-e063-6294a90adc2b
Set id: 65545ca3-4e93-4b59-9e17-4742e086e8e7
Version: 8
Effective Time: 20251231
 
Geri-Care Pharmaceuticals, Corp